These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3309984)

  • 1. To what degree is chemotherapy useful in the treatment of prostatic cancer.
    Murphy GP
    Prog Clin Biol Res; 1987; 243B():247-53. PubMed ID: 3309984
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating chromogranin a and hormone refractory prostate cancer chemotherapy.
    Cabrespine A; Guy L; Gachon F; Curé H; Chollet P; Bay JO
    J Urol; 2006 Apr; 175(4):1347-52. PubMed ID: 16515996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response criteria for prostatic cancer treated by chemotherapy or antiandrogenic therapy].
    Akaza H; Usami M; Kotake T; Matsumura Y; Moriyama N; Imai K; Fuse H; Isaka S; Yamanaka H; Matsumoto K
    Hinyokika Kiyo; 1987 Jun; 33(6):894-904. PubMed ID: 3673839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.
    Kelloff GJ; Coffey DS; Chabner BA; Dicker AP; Guyton KZ; Nisen PD; Soule HR; D'Amico AV
    Clin Cancer Res; 2004 Jun; 10(11):3927-33. PubMed ID: 15173102
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate specific antigen (PSA) may be a poor marker for progression of prostate cancer after treatment with a combination of chemo-hormonal therapies.
    Sartor O
    J La State Med Soc; 2008; 160(2):99-100. PubMed ID: 18681353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy: is it effective in treatment of prostatic cancer?
    Murphy GP
    Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does chemotherapy have a role in the treatment of prostatic cancer?].
    Verbaeys A
    Acta Urol Belg; 1991; 59(4):53-4. PubMed ID: 1819203
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostatic cancer: immunochemical control over chemotherapy].
    Nikolaev AA; Lutskiĭ DL; Nikolaeva NN
    Urologiia; 2000; (3):41-3. PubMed ID: 11186710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it justified to neglect the role of chemotherapy in the treatment of prostatic cancer?
    Jasmin C; Ribaud P
    Prog Clin Biol Res; 1987; 243B():255-8. PubMed ID: 3309986
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer switch may yield map of cancer machinery, targets for drugs.
    Compr Ther; 1998 May; 24(5):276-8. PubMed ID: 9626486
    [No Abstract]   [Full Text] [Related]  

  • 11. [And what is in the works now? Recent developments in therapy of prostate cancer (interview by Constanze Loffler)].
    Miller K
    MMW Fortschr Med; 2009 Jul; 151(30-33):72-3. PubMed ID: 19722471
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin.
    Sridhara R; Eisenberger MA; Sinibaldi VJ; Reyno LM; Egorin MJ
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):631-4. PubMed ID: 9681533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma.
    Eisenberger MA; Bezerdjian L; Kalash S
    Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can PSA velocity serve as a surrogate endpoint in trials of hormone-refractory, metastatic prostate cancer?
    Ward JF
    Nat Clin Pract Urol; 2006 Jun; 3(6):310-1. PubMed ID: 16763642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiblastic chemotherapy in the treatment of cancer of the prostate].
    Pavone-Macaluso M; Caramia G; Vecchioni M
    J Urol Nephrol (Paris); 1972; 78(7):621-34. PubMed ID: 4675962
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer chemotherapy in the era of targeted therapy.
    Michael A; Syrigos K; Pandha H
    Prostate Cancer Prostatic Dis; 2009; 12(1):13-6. PubMed ID: 18521103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The future of chemotherapy of prostatic cancer].
    Grillo-López AJ; Vélez-García E
    Bol Asoc Med P R; 1975 Nov; 67(11):327-30. PubMed ID: 1060454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum chromogranin A in prostate cancer. Preliminary results].
    Reale MG; Marchei GG; Boccia S; Cristofoletti C; Caporossi E; Marchei M; Izzo P; Marchei P
    Minerva Med; 1999; 90(7-8):221-3. PubMed ID: 10719423
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
    Andriole GL
    Eur Urol; 1997; 32 Suppl 3():65-9. PubMed ID: 9267788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topics of prostate cancer].
    Tomida K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):43-6. PubMed ID: 19195118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.